Sakar Healthcare Limited (SAKAR.NS)
INR 310.45
(-0.34%)
INR 310.45
(-0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 244.66 Million | 353.14 Million | 356.98 Million | 145.76 Million | 101.24 Million | 191.03 Million |
| Net Income | 116.7 Million | 168.76 Million | 189.32 Million | 132.32 Million | 122.26 Million | 97.19 Million |
| Depreciation & Amortization | 181.08 Million | 149.86 Million | 96.67 Million | 80.58 Million | 70.79 Million | 60.39 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 996.6 Million | 5.97 Million | 40.88 Million | -68.32 Million | -85.14 Million | 25.29 Million |
| Other non-cash items | -1.04 Billion | 28.54 Million | 30.1 Million | 1.18 Million | -6.67 Million | 8.14 Million |
| Investing Cash Flow | -515.39 Million | -743.76 Million | -903.72 Million | -468.33 Million | -136.76 Million | -248.87 Million |
| Investments in PPE | -595.6 Million | -821.95 Million | -975.31 Million | -355.45 Million | -136.66 Million | -249.07 Million |
| Acquisitions | 48.85 Million | 40.15 Million | - | - | -100 Thousand | - |
| Investment purchases | - | -40.15 Million | -426.49 Million | - | - | - |
| Sales/Maturities of investments | 31.35 Million | 38.03 Million | 356.19 Million | - | - | - |
| Other Investing Activities | 80.21 Million | 40.15 Million | 141.89 Million | -112.87 Million | -1.00 | 201 Thousand |
| Financing Cash Flow | 274.44 Million | 410.96 Million | 546.21 Million | 320.33 Million | 34.8 Million | 57.88 Million |
| Debt repayment | -432.73 Million | -850.07 Million | -458.71 Million | -254.83 Million | -52.09 Million | -27.92 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 774.19 Million | 333.5 Million | 100.8 Million | 78.84 Million | 43.76 Thousand | 116.25 Million |
| Other Financing Activities | 707.17 Million | 927.53 Million | 904.12 Million | 496.32 Million | 86.86 Million | -30.43 Million |
| Accounts receivables | 11.48 Million | -79.08 Million | -41.43 Million | -41.43 Million | 12.69 Million | 13.08 Million |
| Accounts payables | 13.65 Million | -44.16 Million | 25.9 Million | 25.9 Million | 11.19 Million | -4.17 Million |
| Inventory | -123.34 Million | -12.14 Million | 15.13 Million | -47.63 Million | -40.77 Million | -29.25 Million |
| Other working capital | 1.1 Billion | 141.36 Million | 41.28 Million | -5.15 Million | -68.26 Million | 45.64 Million |
| Cash at beginning of period | 913 Thousand | 299 Thousand | 825 Thousand | 3.05 Million | 3.66 Million | 3.62 Million |
| Cash at end of period | 4.65 Million | 933 Thousand | 299 Thousand | 824.64 Thousand | 2.95 Million | 3.66 Million |
| Capital Expenditure | -595.6 Million | -821.95 Million | -975.31 Million | -355.45 Million | -136.66 Million | -249.07 Million |
| Effect of forex changes on cash | - | -19.7 Million | -1000.00 | 351.00 | 100 Thousand | -1000.00 |
| Net cash flow / Change in cash | 3.74 Million | 634 Thousand | -526 Thousand | -2.23 Million | -708.49 Thousand | 45 Thousand |
| Free Cash Flow | -350.93 Million | -468.81 Million | -618.32 Million | -209.68 Million | -35.41 Million | -58.04 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 24.12 Million | 116.7 Million | 31.2 Million | 20.74 Million | 36.35 Million | 28.4 Million |
| Depreciation & Amortization | - | 180.5 Million | - | 44.44 Million | 42.21 Million | 45.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 1 Billion | - | - | - | - |
| Other non-cash items | -24.12 Million | -670.6 Million | -31.2 Million | -20.74 Million | -36.35 Million | -28.4 Million |
| Investing Cash Flow | - | -515.39 Million | - | - | - | - |
| Investments in PPE | - | -595.6 Million | - | - | - | - |
| Acquisitions | - | 48.85 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 31.35 Million | - | - | - | - |
| Other Investing Activities | - | 80.21 Million | - | - | - | - |
| Financing Cash Flow | - | 350.1 Million | - | - | - | - |
| Debt repayment | - | -424.09 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 774.19 Million | - | - | - | - |
| Other Financing Activities | - | 707.17 Million | - | - | - | - |
| Accounts receivables | - | 11.48 Million | - | - | - | - |
| Accounts payables | - | 13.65 Million | - | - | - | - |
| Inventory | - | -123.34 Million | - | - | - | - |
| Other working capital | - | 1.09 Billion | - | - | - | - |
| Cash at beginning of period | - | 933 Thousand | - | 1.09 Million | -83.33 Million | 933 Thousand |
| Cash at end of period | - | 2.57 Million | - | 89.98 Million | 1.09 Million | 91.3 Million |
| Capital Expenditure | - | -595.6 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 1.64 Million | - | 88.89 Million | 84.43 Million | 90.37 Million |
| Free Cash Flow | - | -426.58 Million | - | 88.89 Million | 84.43 Million | 90.37 Million |
1AT
FQT
603016
UNIQ
KSRBF
3996